Find clinical trials for Lung Cancer in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near San Francisco, CA, USA:
chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...
Phase 2
San Francisco, California, United States and 15 other locations
with osimertinib in treating patients with EGFR-mutated stage IV lung cancer. Alisertib may stop the growth of tumor cells ...
Phase 1
San Francisco, California, United States
the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...
Phase 1, Phase 2
San Francisco, California, United States and 30 other locations
Epithelial Growth Factor Receptor (EGFR) -mutant non-small cell lung cancer before surgery. Osimertinib may stop the growth of tumor...
Phase 2
San Francisco, California, United States and 2 other locations
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small cell lung ...
Phase 1
Stanford, California, United States and 25 other locations
, early-stage non-small cell lung cancer....
Phase 2
Oakland, California, United States and 94 other locations
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON...
Phase 1, Phase 2
San Francisco, California, United States and 32 other locations
with pembrolizumab in participants with advanced non-small cell lung cancer (NSCLC) or hormone receptor positive (HR+), human epide....
Phase 1
San Francisco, California, United States and 23 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer i...
Phase 2
Santa Rosa, California, United States and 137 other locations
study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...
Phase 3
San Francisco, California, United States and 230 other locations
Clinical trials
Research sites
Resources
Legal